$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Compositions and methods for the treatment and prevention of hyperproliferative diseases 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/395
출원번호 UP-0261935 (2005-10-28)
등록번호 US-7794713 (2010-10-04)
발명자 / 주소
  • Sabbadini, Roger A.
  • Cavalli, Amy L.
  • Garland, William A.
출원인 / 주소
  • Lpath, Inc.
대리인 / 주소
    BioTechnology Law Group
인용정보 피인용 횟수 : 0  인용 특허 : 246

초록

Monotherapies and combination therapies for treating hyperproliferative disorders are described, as are compositions for performing such methods.

대표청구항

What is claimed is: 1. A method for treating an S1P-associated hyperproliferative disease associated with aberrant cardiac remodeling, comprising administering to a mammal known or suspected to suffer therefrom a therapeutically effective amount of an anti-S1P antibody to lower the effective concen

이 특허에 인용된 특허 (246)

  1. Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL 4), 1,2-Epiminofortimicin B.
  2. Umezawa Hamao (Tokyo JA) Maeda Kenji (Tokyo JA) Kondo Shinichi (Yokohama JA) Umezawa Sumio (Tokyo JA), 1,2′-Di-N-substituted kanamycin B compounds.
  3. Mallams ; Alan K. ; Davies ; David Huw, 1-Desamino-1-hydroxy and 1-desamino-1-epi-hydroxy-4,6-di-o-(aminoglycosyl)-1,3-diaminocyclitols; 1-desamino-1-oxo-4,6-d.
  4. Naito Takayuki (Kawasaki JPX) Nakagawa Susumu (Tokyo JPX) Toda Soichiro (Ohmiya JPX), 1-N-(wa 상세보기
  • Kirst Herbert A. (Indianapolis IN) Truedell Brenda A. (Indianapolis IN), 1-N-Acylated and 1-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides.
  • Kirst Herbert A. (Indianapolis IN) Truedell Brenda A. (Indianapolis IN), 1-N-Acylated and 1-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides and process.
  • Igarashi Kikuo (Itami JPX) Irisawa Junji (Nishinomiya JPX), 1-N-Hetero containing aminoglycoside derivatives.
  • Thomas Michael B. (Deal GB2), 1-N-Kanamycin derivatives.
  • Wright John J. (Cedar Grove NJ) Daniels Peter J. L. (Cedar Grove NJ) Mallams Alan K. (West Orange NJ) Nagabhushan Tattanahalli L. (Parsippany NJ), 1-N-alkyl-aminoglycoside-XK-88 derivatives and methods for their manufacture.
  • Daniels Peter J. L. (Cedar Grove NJ) Nagabhushan Tattanahalli L. (Parsippany NJ), 1-N-aminohydroxyacyl derivatives of gentamicin B.
  • Loibner Hans (Vienna ATX) Streicher Wolfgang (Vienna ATX) Sttz Peter (Vienna ATX), 1-Nitro-aminoglycoside derivatives, pharmaceutical compositions containing them and such derivatives for use as pharmace.
  • Umezawa Sumio (Tokyo JPX) Tsuchiya Tsutomu (Yokohama JPX) Takeuchi Tomio (Tokyo JPX) Umezawa Kazuo (Tokyo JPX) Takahashi Yoshiaki (Tokyo JPX) Shitara Tetsuo (Tokyo JPX) Kobayashi Yoshihiko (Yokohama , 1-n-(4-amino-3-fluoro-2-hydroxybutyryl)-kanamycins.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Johnson Paulette (Zion IL) Nadzan Alex M. (Gurnee IL), 2-Deoxy-2-substituted fortimicin A and B and derivatives.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL 4), 2-Deoxy-2′-N-acyl and alkyl fortimicins A and B.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Johnson Paulette (Zion IL), 2-Deoxy-3-O-Demethylfortimicins.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL 4), 2-Deoxyfortimicin A, 4-N-alkyl and 4-N-acyl-2-deoxyfortimicin B derivatives.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL), 2-Deoxyfortimicin B.
  • Yamamoto Haruo (Chigasaki NY JPX) Daum Sol J. (Albany NY), 2-Hydroxy gentamicin compounds.
  • , 2-N-Acylated and 2-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides and process.
  • Tadanier John S. (Waukegan IL) Martin Jerry R. (Waukegan IL), 2-N-acyl and alkyl 6-epi-fortimicin B and derivatives.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL), 2-O-Substituted sulfonyl derivatives of fortimicin B.
  • Watanabe Isamu (Higashimurayama JPX) Yamaguchi Takashi (Higashimurayama JPX) Kamiya Kazuhiro (Higashimurayama JPX) Mori Toshihito (Higashimurayama JPX), 2′-Deamino aminoglycosides and composition thereof.
  • Daniels Peter J. L. (Cedar Grove NJ) McCombie Stuart (West Orange NJ) Nagabhushan Tattanahalli L. (Parsippany NJ), 2′-Hydroxy-2′-desamino-4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, method for their.
  • Umezawa Hamao (Tokyo JPX) Umezawa Sumio (Tokyo JPX) Ishido Yoshiharu (Chofu JPX) Fukatsu Shunzo (Tokyo JPX), 2′-Modified kanamycins and production thereof.
  • Kirst Herbert A. (Indianapolis IN) Truedell Brenda A. (Indianapolis IN), 2′-N-Acylated and 2′-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides.
  • McAlpine James B. (Libertyville IL), 2′-N-Substituted fortimicin B and derivatives.
  • Tadanier John S. (Waukegan IL) Martin Jerry R. (Waukegan IL 4), 2′N-Acyl and alkyl-6′-N-alkyl- and 6′,6′-di-N-alkyl derivatives of fortimicins A and B.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL 4), 2′N-acyl and alkyl fortimicin B and derivatives, 4,2′-N,N′diacyl and dialkyl fortimicin B derivatives 4-N-acyl-2′-N-.
  • Martin Jerry R. (Waukegan IL) Tadanier John S. (Waukegan IL) Collum Paulette (Zion IL), 3-De-O-methyl-2-N-acyl and alkyl fortimicins A and B.
  • Umezawa Hamao (Tokyo JPX) Umezawa Sumio (Tokyo JPX) Seki Shigeo (Tokyo JPX) Fukatsu Shunzo (Tokyo JPX) Yasuda Shuntaro (Yokohama JPX), 3′,4′-Episulfido kanamycin B compounds.
  • McAlpine James B. (Libertyville IL), 4-N, 2′-N and 4,2′-Di-N-fortimicin AD derivatives.
  • Martin Jerry R. (Waukegan IL), 4-N, 2′-N and 4,2′-Di-N-fortimicin AL derivatives.
  • Martin Jerry R. (Waukegan IL), 4-N, 2′-N and 4,2′Di-N-fortimicins AH and AI.
  • Martin Jerry R. (Waukegan IL), 4-N,2′-N and 4,2′-Di-N-fortimicin AO derivatives.
  • Kurath Paul (Waukegan IL) Tadanier John S. (Waukegan IL) Martin Jerry R. (Waukegan IL), 4-N-Acyl, 2′-N-acyl and 4,2′-N,N′-diacylfortimicin E derivatives.
  • McAlpine James B. (Libertyville IL) DeVault Robert L. (Libertyville IL), 4″-O-Alkylgentamicins and sagamicins.
  • Carney Ronald E. (Gurnee IL) Martin Jerry R. (Waukegan IL) McAlpine James B. (Libertyville IL) Tadanier John S. (Waukegan IL), 5-Deoxyfortimicin A, 2,5-dideoxyfortimicin A and the corresponding 4-N-acyl and alkyl fortimicin B derivatives thereof a.
  • Tadanier John S. (Waukegan IL) Martin Jerry R. (Waukegan IL 4), 6′-Epi-fortimicin A and B derivatives.
  • Daniels Peter J. L. (Cedar Grove NJ) Turner William N. (Bloomfield NJ), 6′-N-alkyl-4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols, methods for their use as antibacterial agents and composition.
  • Tadanier John S. (Waukegan IL) Dunnigan Daniel A. (Winthrop Harbor IL) Freiberg Leslie A. (Waukegan IL) Martin Jerry R. (Waukegan IL), 6′N-Alkyl- and 6′,6′-di-N-alkyl derivatives of fortimicins A and B.
  • Godfrey John Carl (Syracuse NY) Rubinfeld Joseph (Northport NY), 6″-Deoxykanamycin B and 6″-deoxytobramycin.
  • Boguslaski Robert C. (Elkhart IN) Carrico Robert J. (Elkhart IN) Burd John F. (Elkhart IN), b 상세보기
  • Moore James W. (Sandwich GB2), w 상세보기
  • Pierson Martha (Delmar NY), Activated aminoglycosides and aminoglycoside-aminocyclitols pharmaceutical compositions and method of use.
  • Winter, Gregory Paul, Altered antibodies.
  • Daniels ; Peter J. L., Aminoacyl derivatives of aminoglycoside antibiotics.
  • Mallams Alan K. (West Orange NJ) Tkach Richard W. (Linden NJ) Davies David Huw (Macclesfield EN), Aminoglycoside 66-40C, method for its manufacture, method for its use as an intermediate in the preparation of known ant.
  • Fujii Tadashiro (Mishima JPX) Satoi Shuzo (Shizuoka JPX) Muto Naoki (Shizuoka JPX) Hayashi Mitsuo (Shizuoka JPX) Kodama Akira (Shizuoka JPX) Otani Masaru (Shizuoka JPX), Aminoglycoside antibiotic G-367-1 and method for the production thereof.
  • Fujii Tadashiro (Mishima JPX) Satoi Shuzo (Shizuoka JPX) Muto Naoki (Shizuoka JPX) Hayashi Mitsuo (Shizuoka JPX) Kodama Akira (Shizuoka JPX) Otani Masaru (Shizuoka JPX), Aminoglycoside antibiotic G-367-2.
  • Nagabhushan Tattanahalli L. (Parsippany NJ) Turner William N. (Bloomfield NJ) Cooper Alan (West Caldwell NJ), Aminoglycoside antibiotic compounds.
  • Igarashi Kikuo (Itami JP), Aminoglycoside antibiotic derivatives and method of use.
  • Magerlein Barney J. (Portage MI), Aminoglycoside antibiotics.
  • Magerlein Barney J. (Portage MI), Aminoglycoside antibiotics and intermediates.
  • Fenner Brian Richard (Broadstairs EN) Hardstone John David (Deal EN) Graves Leeming Michael Ramond (Canterbury EN), Aminoglycoside antibiotics and intermediates therefor.
  • Oka Yoshihiko (Kawagoe JPX) Ishida Hitoshi (Ageo JPX) Morioka Moto (Niizo JPX) Numasaki Yoso (Ageo JPX) Yamafuji Tsutomu (Tokyo JPX) Osono Takashi (Tokyo JPX) Umezawa Hamao (Tokyo JPX), Aminoglycoside antibiotics and process for production thereof.
  • Watanabe Isamu (Higashimurayama JPX) Kamiya Kazuhiro (Higashimurayama JPX) Torii Takahiro (Chofu JPX) Mori Toshihito (Higashimurayama JPX), Aminoglycoside compounds.
  • Watanabe Isamu (Higashimurayama JPX) Kamiya Kazuhiro (Higashimurayama JPX) Torii Takahiro (Chofu JPX) Mori Toshihito (Hagashimurayama JPX), Aminoglycoside compounds, processes for production thereof, and pharamaceutical composition containing the same.
  • Takaya Takao (Kawanishi JPX) Yasuda Nobuyoshi (Nishinomiya JPX) Tsutsumi Hideo (Toyonaka JPX) Matsuda Keiji (Takatsuki JPX), Aminoglycoside derivatives.
  • Takaya Takao (Kawanishi JPX) Yasuda Nobuyoshi (Nishinomiya JPX) Tsutsumi Hideo (Yuhigaoka JPX) Matsuda Keiji (Takatsuki JPX), Aminoglycoside derivatives.
  • Gero Stephan (Orsay FRX) Mercier Daniel (Gif-sur-Yvette FRX) Olesker Alain (Gif-sur-Yvette FRX) Cier Andre (Neuilly-sur-Seine FRX), Aminoglycoside-aminocyclitol derivatives and method of use.
  • Gasc Jean-Claude (Bondy FRX) Rettien Claude (Montreuil FRX), Aminoglycosides and method of use.
  • Watanabe Isamu (Higashimurayama JPX) Yamaguchi Takashi (Tokyo JPX) Kamiya Kazuhiro (Higashimurayama JPX) Mori Toshihito (Higashimurayama JPX) Umezawa Hamao (Tokyo JPX) Umezawa Sumio (Tokyo JPX) Tsuch, Aminoglycosides and use thereof.
  • Kawaguchi Hiroshi (Tokyo JPX) Konishi Masataka (Yokohama JPX) Tsuno Takashi (Higashimurayama JPX) Miyaki Takeo (Yokohama JPX), Antibacterial agents Bu-2349A and B and method of using same.
  • Chazan Jean-Bernard (Paris FR) Coussediere Daniel (Villejuif FR) Gasc Jean-Claude (Bondy FR), Antibiotic aminoglycosides, and process of preparation.
  • Chazan Jean Bernard (Paris FR) Coussediere Daniel (Villejuif FR) Gasc Jean-Claude (Bondy FR), Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions.
  • Chazan Jean-Bernard (Paris FR) Gasc Jean-Claude (Bondy FR), Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions.
  • Coussediere Daniel (Villejuif FR) Gasc Jean-Claude (Bondy FR), Antibiotic aminoglycosides, processes of preparation and pharmaceutical compositions.
  • Whaley Howard A. (Portage MI) Coats John H. (Kalamazoo MI), Antibiotic and fermentation process of preparing.
  • Kawaguchi Hiroshi (Tokyo JA) Tomita Koji (Kawasaki JA) Fujisawa Kei-Ichi (Kamifukuoka JA) Tsukiura Hiroshi (Mitaka JA), Antibiotic complex Bu 2183.
  • Weinstein Marvin J. (East Brunswick NJ) Wagman Gerald H. (East Brunswick NJ) Marquez Joseph A. (Montclair NJ), Antibiotics sisomicin and verdamicin I and complex containing same.
  • Winter Gregory P. (Cambridge GB3) Duncan Alexander R. (Wimbledon GB3) Burton Dennis R. (Sheffield GB3), Antibodies with altered effector functions.
  • Man Sung Co ; David A. Scheinberg ; Cary L. Queen, Antibodies with increased binding affinity.
  • Toole John J. ; Griffin Linda C. ; Bock Louis C. ; Latham John A., Aptamer analogs specific for biomolecules.
  • Weiner George ; Gingrich Roger ; Link Brian K. ; Tso J. Yun, Bispecific antibody effective to treat B-cell lymphoma and cell line.
  • Tso J. Yun ; Kostelny Sheri A. ; Cole Michael S., Bispecific antibody heterodimers.
  • Iwashita Yuji (Kawasaki JPX) Ajisaka Katsumi (Yokohama JPX), Blood substitute containing modified hemoglobin.
  • Baker Joffre (El Granada CA) Chien Kenneth (La Jolla CA) King Kathleen (Pacifica CA) Pennice Diane (Burlingame CA) Wood William (San Mateo CA), Cardiac hypertrophy factor and uses therefor.
  • Diack Archibald W. (Portland OR) Welborn Warren S. (Portland OR) Rullman Robert G. (Beaverton OR), Cardiac resuscitator and monitoring apparatus.
  • Darfler Frederick J. (Derwood MD), Cell culture medium with antioxidant.
  • Seidman Jonathan G. (Milton MA) Jakobovits Aya (Menlo Park CA), Cells homozygous for disrupted target loci.
  • Nakagawa Yasushi (Kawanishi JPX) Ito Takashi (Osaka JPX), Chemically modified protein with polyethyleneglycol.
  • Cardinal John R. (Old Lyme CT) Curatolo William J. (Old Lyme CT) Ebert Charles D. (Brewster NY), Chitosan compositions for controlled and prolonged release of macromolecules.
  • Sabbadini,Roger A., Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation.
  • Sabbadini, Roger A., Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor.
  • Sabbadini, Roger A., Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor.
  • Holoshitz Joseph ; Shayman James A. ; Tan Shi-Yu, Compositions and methods for treating autoimmune disease.
  • Mavunkel Babu J. ; Lewicki John A. ; Liu David Y. ; Schreiner George F., Compounds and methods to treat cardiac failure and other disorders.
  • Mitra Gautam (Kensington CA), Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer.
  • Horii Satoshi (Sakai JA) Kameda Yukihiko (Toyonaka JA) Mizokami Nariakira (Suita JA), Deoxyaminoglycoside antibiotic derivatives.
  • Pfeiffer Francis R. (Cinnaminson NJ), Deoxyglucose derivatives.
  • Umezawa Hamao (Tokyo JPX) Umezawa Sumio (Tokyo JPX) Fukatsu Shunzo (Tokyo JPX) Yoneta Toshio (Yokohama JPX) Wakazawa Tadashi (Yokohama JPX), Derivative of kanamycin A and a process for the preparation thereof.
  • Umezawa Hamao (Tokyo JPX) Maeda Kenji (Tokyo JPX) Kondo Shinichi (Yokohama JPX) Umezawa Sumio (Tokyo JPX) Tsuchiya Osamu (Yokohama JPX) Fukatsu Shunze (Tokyo JPX), Derivatives of kanamycin A.
  • Chazan Jean-Bernard (Paris FRX) Gasc Jean-Claude (Bondy FRX), Desoxystreptamine derivatives, salts, pharmaceutical compositions and method of use.
  • Spickermann Reiner,DEX, Dialysis machine for the removal of toxic substances from the blood with agents for the decalcification of a dialysis liquid circulation as well as process for determining the degree of calcification.
  • Kondo Shinichi (Yohohama JPX) Shibahara Seiji (Machida JPX) Usui Takayuki (Kawasaki JPX) Kudo Toshiaki (Yokohama JPX) Gomi Shuichi (Tokyo JPX) Tamura Atsushi (Yokohama JPX) Ikeda Yoko (Tokyo JPX) Ike, Dibekacin derivatives and arbekacin derivatives active against resistant bacteria.
  • Kondo Shinichi (Yokohama JPX) Shibahara Seiji (Machida JPX) Usui Takayuki (Kawasaki JPX) Kudo Toshiaki (Yokohama JPX) Gomi Shuichi (Tokyo JPX) Tamura Atsushi (Yokohama JPX) Ikeda Yoko (Tokyo JPX) Ike, Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof.
  • Au-Young Janice ; Guegler Karl J., Edg-1-receptor homolog.
  • Lerner Richard (La Jolla CA) Janda Kim (San Diego CA) Brenner Sydney (Cambridge GB2), Encoded combinatorial chemical libraries.
  • Hiraga Kentaro (Kyoto JA) Okutani Tetsuya (Osaka JA) Asako Tsunehiko (Kyoto JA) Yoshioka Kouichi (Kyoto JA), Epiminodeaminodeoxyaminoglycoside antibiotics and intermediates.
  • Tomita Koji (Kawasaki JA) Tsukiura Hiroshi (Mitaka JA) Kawaguchi Hiroshi (Tokyo JA), Fermentation process for producing apramycin and nebramycin factor V′.
  • Yamamoto Haruo (11-16 ; Matsukazedai Chigasaki City ; Kanagawa Prefecture JPX), Fermentative process for preparing antibiotics of the gentamicin class.
  • Wahlig Helmut (Darmstadt DEX) Dingeldein Elvira (Dreieich DEX) Kirchlechner Richard (Rott a. Inn DEX) Orth Dieter (Darmstadt DEX) Rogalski Werner (Alsbach DEX), Flavonoid phosphate salts of aminoglycoside antibiotics.
  • Goldstein Alma W. (Lake Bluff IL) Fager Earl E. C. (Lake Villa IL), Fortimicin AL.
  • Seely John H. (Lake Forest IL), Fortimicin AN.
  • Collum Paulette (Zion IL) Fager Earl E. C. (Lake Villa IL), Fortimicin AO.
  • Tadanier John S. (Waukegan IL) Martin Jerry R. (Waukegan IL), Fortimicin B-1,2:4,5-bis-carbamates.
  • Post Gerald G. (Kenosha WI), Fortimicin E.
  • Watanabe Isamu (Higashimurayama JPX) Iwasaki Akio (Higashimurayama JPX) Mori Toshihito (Higashimurayama JPX), Fortimicin aminoglycosides, process for production thereof, and use thereof.
  • Goldstein Alma W. (Lake Bluff IL) Fager Earl E. C. (Lake Villa IL), Fortimicins AH and AI.
  • Carney Ronald E. (Gurnee IL), Fortimicins AM and AP.
  • Carney Ronald E. (Gurnee IL) McAlpine James B. (Libertyville IL), Fortimicins AM and AP derivatives.
  • Rutter William J. (San Francisco CA) Santi Daniel V. (San Francisco CA), General method for producing and selecting peptides with specific properties.
  • Chen Hao (Adelphia MD) Radmer Richard (Baltimore MD), Generation and screening of synthetic drug libraries.
  • Kucherlapati Raju ; Jakobovits Aya ; Klapholz Sue ; Brenner Daniel G. ; Capon Daniel J., Generation of Xenogenetic antibodies.
  • Collins John,DEX ; Rottgen Peter,DEX, Generation of diversity in combinatorial libraries.
  • Kucherlapati Raju ; Jakobovits Aya ; Kalpholz Sue ; Brenner Daniel G. ; Capon Daniel J., Generation of xenogeneic antibodies.
  • Iwasaki Keiji (Kawasaki JPX) Iwashita Yuji (Kawasaki JPX) Okami Taketoshi (Yokohama JPX), Hemoglobin combined with a poly(alkylene oxide).
  • Boguslaski Robert C. (Elkhart IN) Carrico Robert J. (Bremen IN) Christner James E. (Ann Arbor MI), Heterogenous specific binding assay employing a cycling reactant as label.
  • Kucherlapati Raju ; Jakobovits Aya ; Brenner Daniel G. ; Capon Daniel J. ; Klapholz Sue, Human antibodies derived from immunized xenomice.
  • Kucherlapati Raju ; Jakobovits Aya ; Klapholz Sue ; Brenner Daniel G. ; Capon Daniel J., Human antibodies derived from immunized xenomice.
  • Barbas, III,Carlos F.; Rader,Christoph, Humanization of murine antibody.
  • Goldstein,Neil I.; Giorgio,Nicholas A.; Jones,Steven Tarran; Saldanha,Jose William, Humanized anti-EGF receptor monoclonal antibody.
  • Lin Augustine Y., Humanized antibodies and uses thereof.
  • Co Man Sung ; Tso J. Yun, Humanized antibodies reactive with GPIIB/IIIA.
  • Co Man Sung, Humanized antibodies reactive with L-selectin.
  • Vasquez Maximiliano ; Landolfi Nicholas F. ; Tsurushita Naoya ; Queen Cary L., Humanized antibodies to .gamma.-interferon.
  • Philip R. Tempest GB; William J. Harris GB; Frank J. Carr GB, Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes.
  • Wayne A. Marasco ; Joyce Lavecchio ; Abner Mhashilkar ; Urban Ramstedt ; David Ring ; Bridget Eberhardt ; Julie Porter-Brooks, Humanized antibody and uses thereof.
  • Queen Cary L. (Los Altos CA) Co Man Sung (Cupertino CA) Schneider William P. (Mountain View CA) Landolfi Nicholas F. (Milpitas CA) Coelingh Kathleen L. (San Francisco CA) Selick Harold E. (Belmont CA, Humanized immunoglobulins.
  • Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  • Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  • Queen Cary L. ; Selick Harold E., Humanized immunoglobulins and methods of making the same.
  • Richardson Kenneth (Canterbury GB2) Plews Rhona M. (Canterbury GB2) Wright James R. (Deal GB2), Hydroxyalkyl derivatives of aminoglycoside antibiotics.
  • Bertoglio-Matte Jacques H. (Seattle WA), Immediate ligand detection assay.
  • Ladner Robert C. (Ijanisville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD), Immunoaffinity purification methods using single polypeptide chain binding molecules.
  • Ladner Robert C. (Ijamsville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD), Immunoassay methods using single polypeptide chain binding molecules.
  • David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  • Ladner Robert C. (Ijamsville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD), Immunotheraphy using single chain polypeptide binding molecules.
  • Goroff Diana K. (Chevy Chase MD), In-vitro method for producing antigen-specific human monoclonal antibodies.
  • Co Man Sung ; Scheinberg David A. ; Queen Cary L., Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region.
  • Collum Paulette (Zion IL), Isofortimicin.
  • Umezawa Hamao (Tokyo JPX) Kondo Shinichi (Yokohama JPX), Kanamycin C derivatives.
  • Takaya, Takao; Yasuda, Nobuyoshi; Tsutsumi, Hideo; Matsuda, Keiji, Kasugamycin derivatives, pharmaceutical compositions and method of use.
  • Stracher Alfred ; Kesner Leo, Liposome preferentially traveling to cardiac and skeletal muscles.
  • Ryan, Patrick J.; Davis, Michael A.; Melchior, Donald L., Liposomes containing modified cholesterol for organ targeting.
  • Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  • Litman David J. (Palo Alto CA) Harel Zvi (Stanford CA) Ullman Edwin F. (Atherton CA), Macromolecular environment control in specific receptor assays.
  • Sarnoff Stanley J. (Bethesda MD), Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms.
  • Burton James A. (Amesbury MA) Hoop ; Jr. Bernard (Wakefield MA), Method and apparatus for ligand detection.
  • Mather Jennie P. (Millbrae CA) Tsao Mary C. (Burlingame CA), Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins.
  • Carter, Paul J.; Presta, Leonard G., Method for making humanized antibodies.
  • Paul J. Carter ; Leonard G. Presta, Method for making humanized antibodies.
  • Hiatt Andrew C. ; Ma Julian K.-C.,GBXITX SE231PE ; Lehner Thomas,GBXITX EN40LL ; Mostov Keith E., Method for producing immunoglobulins containing protection proteins in plants and their use.
  • Umezawa ; Hamao ; Kondo ; Shinichi, Method for production of kanamycin C and its derivatives.
  • Igarashi Yasuyuki (Seattle WA) Yatomi Yutaka (Seattle WA) Ohta Hideki (Seattle WA) Hakomori Sen-Itiroh (Mercer Island WA), Method for quantifying sphingosine and for diagnosing platelet activation.
  • Furuno Kouji (Kokubunji JA) Okazaki Akira (Oyama JA) Matsubara Syuzo (Fuchu JA) Shiba Motoharu (Omiya JA) Shioya Akitoshi (Kawagoe JA), Method for reducing side effects of aminoglycoside antibiotics and composition therefor.
  • Gado Istvan (Budapest HUX) Jekkel nee Bokany Antonia (Budapest HUX) Szvoboda Gyrgy (Budapest HUX) Jarai Miklos (Budapest HUX) Piukovich Sandor (Budapest HUX) Istvan Sandor (Szentendre HUX), Method for the preparation of antibiotic sisomicin.
  • Jarai Miklos (Budapest HUX) Piukovich Sandor (Budapest HUX) Istvan Sandor (Szentendre HUX) Gado Istvan (Budapest HUX) Szell Valeria (Budapest HUX) Barta Istvan (Budapest HUX), Method for the production of sisomicin.
  • Tabas, Ira; Schissel, Scott L.; Williams, Kevin Jon, Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase.
  • Isner Jeffrey M., Method for treating ischemic tissue.
  • Daniels Peter J. L. (Cedar Grove NJ) Marquez Joseph A. (Montclair NJ), Method of isolating gentamicin C2a.
  • Light Susan ; Queen Cary, Method of preventing acute rejection following solid organ transplantation.
  • Carney Ronald E. (Gurnee IL) Martin Jerry R. (Waukegan IL) McAlpine James B. (Libertyville IL) Tadanier John S. (Waukegan IL), Method of producing 2-deoxyfortimicin A.
  • McAlpine James B. (Libertyville IL) Carney Ronald E. (Gurnee IL), Method of producing 2-epi-fortimicin A.
  • Kloss John (Gurnee IL) Nadzan Alex M. (Gurnee IL), Method of producing 3-O-demethylfortimicin B,4-N-alkylfortimicin B derivatives and related aminoglycoside antibiotics.
  • Borrebaeck Carl (Lund SEX) Danielsson Lena (Lund SEX) Moller Susanna (Lund SEX), Method of producing human monoclonal antibodies and kit therefor.
  • Ashby Matthew (San Aselmo CA) Rine Jasper (Moraga CA), Methods for drug screening.
  • Gold Larry (Boulder CO) Tuerk Craig (Boulder CO), Methods for identifying nucleic acid ligands.
  • Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Methods for producing multivalent antigen-binding proteins.
  • Gallop Mark A. (Los Altos CA) Murphy Martin A. (Mountain View CA), Methods for synthesizing diverse collections of pyrrolidine compounds.
  • Weinstein Marvin Joseph (East Brunswick NJ) Daniels Peter John Lovell (Cedar Grove NJ) Wagman Gerald Howard (East Brunswick NJ) Testa Raymond Thomas (Verona NJ), Methods for the preparation of semi-synthetic aminocyclitol aminoglycoside antibiotics.
  • Holmes Christopher P. (Sunnyvale CA), Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof.
  • Mandeville Rosemonde,CAX ; Popkov Mikhail,CAX, Methods of generating novel peptides.
  • Wei Yong (Branchburg NJ) Mayhew Eric (Monmouth Junction NJ) Ahmad Imran (Plainsboro NJ) Janoff Andrew S. (Yardley PA), Methods of treatment using pharmaceutically active ceramide-related compositions.
  • Chang Chung Nan ; Landolfi Nicholas F. ; Martin Ulrich,DEX, Monoclonal antibodies specific for the platelet derived growth factor .beta. receptor and methods of use thereof.
  • Garrard Lisa J. ; Henner Dennis J. ; Bass Steven ; Greene Ronald ; Lowman Henry B. ; Wells James A. ; Matthews David J., Monovalent phage display.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Morpholino-subunit combinatorial library and method.
  • Boss Michael A. (Slough GBX) Kenten John H. (High Wycombe GBX) Emtage John S. (High Wycombe GBX) Wood Clive R. (Near Fordingbridge GBX), Multichain polypeptides or proteins and processes for their production.
  • Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Multivalent antigen-binding proteins.
  • Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Multivalent antigen-binding proteins.
  • Tso J. Yun ; Cole Michael S. ; Anasetti Claudio, Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same.
  • Davis Frank F. (19 Farmingdale Rd. East Brunswick NJ 08816) Van Es Theodorus (313 Overbrook Rd. Piscataway NJ 08854) Palczuk Nicholas C. (45 W. Franklin St. Bound Brook NJ 08805), Non-immunogenic polypeptides.
  • Mallams Alan K. (West Orange NJ) Davies David Huw (Macclesfield EN), Novel 4,6-di-O-(aminoglycosyl)-2-deoxystreptamine, method for its manufacture, method for its use as an antiprotozoal ag.
  • Igarashi Kikuo (Itami JPX) Honma Tsunetoshi (Ikoma JPX), Novel aminoglycoside derivatives.
  • Igarashi Kikuo (Itami JPX) Irisawa Junji (Nishinomiya JPX) Honma Tsunetoshi (Ikoma JPX), Novel aminoglycoside derivatives.
  • Igarashi Kikuo (Itami JPX) Sugawara Tamio (Mino JPX), Novel aminoglycoside derivatives.
  • Mangia Alberto (Milan ITX) Giobbio Vicenzo (Turin ITX) Ornato Giorgio (Ivrea ITX), Novel process for the synthesis of amikacin.
  • Magerlein Barney J. (Portage MI), O-Glycoside ortho esters of neamine containing compounds.
  • Cook Phillip D. (Carlsbad CA) Kiely John (San Diego CA) Sprankle Kelly (Vista CA), Peptide nucleic acid combinatorial libraries and improved methods of synthesis.
  • Mulligan-Kehoe Mary Jo (Springfield VA), Phage-display of immunoglobulin heavy chain libraries.
  • Wei Yong (Branchburg NJ) Mayhew Eric (Monmouth Junction NJ) Ahmad Imran (Plainsboro NJ) Janoff Andrew S. (Yardley PA), Pharmaceutically active ceramide-related compounds.
  • Shimizu Kimihiro (Yoshikawa JPX) Nakahara Tsuguji (Tokyo JPX) Kinoshita Taketoshi (Koshigaya JPX) Takatsuka Jun (Kawasaki JPX) Igarashi Michiko (Musashino JPX), Plasminogen activator derivatives.
  • Queen Cary L. (Los Altos CA) Schneider William P. (Mountain View CA) Selick Harold E. (Belmont CA), Polynucleotides encoding improved humanized immunoglobulins.
  • Cron Martin J. (Fayetteville NY) Keil John G. (Manlius NY) Lin Jeng S. (Clay NY) Ruggeri Mariano (Liverpool NY) Walker Derek (Jamesville NY), Preparation of 1-N-[wa 상세보기
  • Cron Martin J. (Fayetteville NY) Keil John G. (Manlius NY) Lin Jeng S. (Clay NY) Ruggeri Mariano V. (Liverpool NY) Walker Derek (Jamesville NY), Preparation of 1-N-[wa 상세보기
  • Holton Robert A. (Tallahassee FL), Preparation of substituted isoserine esters using b 상세보기
  • Ross ; Barry C., Process for .omega.-amino-2-hydroxyalkyl derivatives of aminoglycoside antibiotics.
  • Mallams ; Alan K. ; Davies ; David Huw, Process for preparing 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols and novel 1-epimers and 1-N-alkyl derivatives produ.
  • Giobbio Vincenzo (Turin ITX) Ambrosini Leonardo (Bergamo ITX), Process for preparing amikacin.
  • Igarashi Kikuo (Itami JPX) Sugawara Tamio (Mino JPX), Process for preparing aminoglycoside derivatives.
  • Tann Chou-Hong (Berkeley Heights NJ) Thiruvengadam Tiruvettipuram K. (Edison NJ) Chiu John S. (Parsippany NJ) Colon Cesar (Rahway NJ) Green Michael D. (Paterson NJ), Process for preparing isepamicin.
  • Rosenbrook ; Jr. William (Libertyville IL), Process for producing 3-O-demethylaminoglycoside and novel 3-O-demethylfortimicin derivatives.
  • Oka Yoshihiko (Kawagoe JPX) Ishida Hitoshi (Ageo JPX) Morioka Moto (Niiza JPX) Numusaki Yoso (Ageo JPX) Yamafuji Tsutomu (Tokyo JPX) Osono Takashi (Tokyo JPX) Umezawa Hamao (Tokyo JPX), Process for production of aminoglycoside antibiotics.
  • Nagabhushan Tattanahalli Lakshminarayan (Parsippany NJ), Process for the manufacture of 6′-N-alkyl derivatives of sisomicin and verdamicin; novel intermediates useful therein,.
  • Schreiber Richard Henry (Canastota NY) Keil John Gerard (Manlius NY), Process for the preparation of 1-[L-(-)-ga 상세보기
  • Dall\Asta Leone (Pavia ITX) Garegnani Eugenio (Marcallo Con Casone ITX), Process for the preparation of amikacin precursors.
  • Dall\Asta Leone (Pavia ITX) Garegnani Eugenio (Marcallo con Casone ITX), Process for the preparation of amikacin precursors.
  • Stadler, Peter; Koebernick, Wolfgang; Samaan, Samir; Gau, Wolfgang, Process for the preparation of purified aminoglycoside antibiotics.
  • Horii Satoshi (Osaka JA) Nogami Ikuo (Kyoto JA) Hasegawa Toru (Kawani JA) Yoneda Masahiko (Uozakinaka JA), Process for the preparation of xylostasin.
  • Mangia Alberto,ITX, Process for the synthesis of amikacin.
  • Nagabhushan Tattanahalli L. (Parsippany NJ) Turner William N. (Bloomfield NJ) Cooper Alan (Parsippany NJ), Process of selectively blocking amino functions in aminoglycosides using transition metal salts and intermediates used t.
  • Umezawa Hamao (Tokyo JPX) Umezawa Sumio (Tokyo JPX) Tsuchiya Tsutomu (Yokohama JPX) Takagi Yasushi (Yokohama JPX) Jikihara Tomo (Kawasaki JPX), Production of a selectively protected N-acylated derivative of an aminoglycosidic antibiotic.
  • Surani Azim M. (Cambridge GB3) Neuberger Michael S. (Cambridge GB3) Bruggemann Marianne (Cambridge GB3), Production of antibodies from transgenic animals.
  • Hoogenboom Hendricus R. J. M. (Cambridge GBX) Baier Michael (Frankfurt DEX) Jespers Laurent S. A. T. (Tervuren BEX) Winter Gregory P. (Cambridge GBX), Production of chimeric antibodies - a combinatorial approach.
  • Fell H. Perry (Redmond WA) Folger Bruce Kim R. (Seattle WA), Production of chimeric antibodies by homologous recombination.
  • Arcamone ; Federico ; Cassinelli ; Giuseppe, Protected pseudotrisaccharide intermediate for paromomycin and neomycin derivatives.
  • Cleveland William L. (New York NY) Erlanger Bernard F. (Whitestone NY), Protein-free culture medium.
  • Acevedo Oscar L. (San Diego CA) Hebert Normand (San Marcos CA), Pyrrolidine-containing monomers and oligomers.
  • Winter Gregory P. (Cambridge GBX), Recombinant altered antibodies and methods of making altered antibodies.
  • Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
  • Weng Litai (Mountain View CA) Gibbons Iam (Menlo Park CA), Reducing interference in ligand-receptor binding assays.
  • Gamble, Jennifer; Vadas, Mathew; Xia, Pu; Barter, Phillip; Rye, Kerry-Anne; Wattenberg, Brian; Pitson, Stuart, Screening method for an agent having an effect on a sphingosine kinase signaling pathway.
  • Carney Ronald E. (Gurnee IL) McAlpine James B. (Libertyville IL) Perun Thomas J. (Libertyville IL), Seldomycin factor 5 derivative.
  • Carney Ronald E. (Gurnee IL) McAlpine James B. (Libertyville IL), Seldomycin factor 5 derivatives.
  • Petersen Uwe (Leverkusen DEX) Voss Eckart (Cologne DEX) Stadler Peter (Haan DEX), Selectively protected 1-N-(w 상세보기
  • Weinstein Marvin J. (East Brunswick NJ) Daniels Peter J. L. (Cedar Grove NJ) Wagman Gerald H. (East Brunswick NJ) Testa Raymond (Verona NJ), Semi-synthetic aminocyclitol aminoglycoside antibiotics and methods for the preparation thereof.
  • Zhao Min,CNX ; Fan Jin,CNX ; Liu Jun,CNX ; Hu Xiaoling,CNX ; Fan Minqi,CNX, Semisynthetic 1-N-ethylgentamicin C.sub.1a and method for its preparation.
  • Cartaya Oscar A. (125 Pleasant St. ; Apt. #401 Brookline MA 02146), Serum-free cell culture media.
  • Baker, Paul E., Serum-free cell culture medium and process for making same.
  • Kumar Sudhir (18901 Springfield Flossmoor IL 60422), Serum-free, synthetic, completely chemically defined tissue culture media.
  • Ladner Robert C. (Ijamsville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD), Single polypeptide chain binding molecules.
  • Ladner Robert C. (Ijamsville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD), Single polypeptide chain binding molecules.
  • Petersen Uwe (Leverkusen DEX) Stadler Peter (Haan DEX) Lockhoff Oswald (Leverkusen DEX) Zeiler Hans-Joachim (Velbert DEX) Metzger Karl G. (Wuppertal DEX), Sisomicin compounds.
  • Petersen Uwe (Leverkusen DEX) Metzger Karl G. (Wuppertal DEX) Zeiler Hans-Joachim (Velbert DEX) Stadler Peter (Haan DEX) Voss Eckart (Cologne DEX), Sisomicin derivatives, processes for their production and their medicinal use.
  • Ellman Jonathan A. (Berkeley CA), Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support.
  • Liotta, Dennis C.; Merrill, Jr., Alfred H.; Keane, Thomas E.; Bhalla, Kapil N.; Schmelz, Eva M, Sphingolipid derivatives and their methods of use.
  • Rosenkrantz Bernard E. (Bloomfield NJ) Stupak Elliot (West Caldwell NJ), Stabilized aminoglycoside antibiotic formulations.
  • Hines, Jacqueline; Carpenter, Charles; Solie, Leland P., Surface-acoustic-wave pressure sensor and associated methods.
  • Kavadias Gerry (St-Lambert CA) Belleau Bernard (Westmount CA), Synthesis of cis-1,4-cyclohexadiene dioxide.
  • Canas-Rodriquez Antonio (8 Saint Martin\s Pl. Canterbury GB2 CT1 1QD), Synthetic aminoglycosides.
  • Regen Steven L. (Milwaukee WI), Synthetic phosphatidyl cholines useful in forming liposomes.
  • Segal David M. (Rockville MD) Perez Pilar (Bethesda MD), Target specific cross-linked heteroantibodies.
  • Brown Scott M. (San Diego CA), Tissue factor based prothrombin time reagent.
  • Kavadias ; Gerry ; Belleau ; Bernard R., Total synthesis of 2,5-dideoxystreptamines.
  • Krimpenfort Paulus J. A. (Amsterdam NLX) Berns Antonius J. M. (Spaarndam NLX), Transgenic mice depleted in a mature lymphocytic cell-type.
  • Lonberg Nils ; Kay Robert M., Transgenic non-human animals capable of producing heterologous antibodies.
  • 문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로